Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Absci Corp (ABSI)

Absci Corp (ABSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 307,814
  • Shares Outstanding, K 114,856
  • Annual Sales, $ 5,720 K
  • Annual Income, $ -110,570 K
  • EBIT $ -90 M
  • EBITDA $ -55 M
  • 60-Month Beta 2.18
  • Price/Sales 54.64
  • Price/Cash Flow N/A
  • Price/Book 1.53

Options Overview Details

View History
  • Implied Volatility 247.89% ( +154.87%)
  • Historical Volatility 81.02%
  • IV Percentile 98%
  • IV Rank 60.83%
  • IV High 383.11% on 09/12/24
  • IV Low 37.86% on 10/07/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 77
  • Volume Avg (30-Day) 352
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 7,879
  • Open Int (30-Day) 11,674

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.23
  • Number of Estimates 4
  • High Estimate -0.20
  • Low Estimate -0.25
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +8.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.45 +4.08%
on 11/19/24
4.47 -42.89%
on 11/11/24
-1.49 (-36.88%)
since 10/21/24
3-Month
2.45 +4.08%
on 11/19/24
4.60 -44.57%
on 08/26/24
-1.80 (-41.38%)
since 08/21/24
52-Week
1.35 +88.89%
on 11/28/23
6.72 -62.05%
on 04/09/24
+1.19 (+87.50%)
since 11/21/23

Most Recent Stories

More News
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference

ABSI : 2.55 (-4.85%)
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care

/CNW/ -- Healthcare is undergoing a transformative shift, with new technologies enabling breakthroughs that were once unimaginable. According to the World...

AVAI : 0.5300 (+1.92%)
TWST : 41.66 (+1.34%)
SYK : 390.14 (+1.16%)
ABSI : 2.55 (-4.85%)
RDNT : 81.30 (-1.05%)
Inside the AI-Healthcare Boom: Breakthroughs in Diagnostics and Personalized Treatment

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – A recent World Economic Forum report highlights AI's potential to ease the strain on healthcare systems...

MSFT : 412.87 (-0.63%)
NVDA : 146.67 (+0.53%)
TWST : 41.66 (+1.34%)
AVAI : 0.5300 (+1.92%)
ABSI : 2.55 (-4.85%)
RXRX : 5.75 (-4.80%)
EXAI : 4.84 (+3.20%)
Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

ABSI : 2.55 (-4.85%)
Absci to Host R&D Day on December 12, 2024

ABSI : 2.55 (-4.85%)
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI

ABSI : 2.55 (-4.85%)
Absci to Participate in Upcoming Investor Conferences

ABSI : 2.55 (-4.85%)
Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

ABSI : 2.55 (-4.85%)
1 'Strong Buy' Penny Stock to Invest in AI Drug Development

Investors seeking AI-led drug development opportunities can consider this top-rated biotech stock under $5.

AZN : 64.26 (+1.68%)
ABSI : 2.55 (-4.85%)
AI and Biotech Developers Lead the Charge in the Next Healthcare Transformation

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group – Earlier this year, US President Joe Biden and his administration put out a new executive order on safe, secure, and...

AVAI : 0.5300 (+1.92%)
MYO : 4.80 (-2.44%)
PRCT : 94.45 (+1.89%)
ISRG : 550.62 (+1.62%)
ABSI : 2.55 (-4.85%)

Business Summary

Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. The company's Creation(TM) Platform involved in discovery of novel biotherapeutic drug candidates and generation of the cell lines to manufacture them in a single...

See More

Key Turning Points

3rd Resistance Point 2.83
2nd Resistance Point 2.76
1st Resistance Point 2.66
Last Price 2.55
1st Support Level 2.48
2nd Support Level 2.41
3rd Support Level 2.31

See More

52-Week High 6.72
Fibonacci 61.8% 4.67
Fibonacci 50% 4.03
Fibonacci 38.2% 3.40
Last Price 2.55
52-Week Low 1.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar